Skip to main content

Table 3 Summary of experimental data of insulin growth factor-1 (IGF-1) receptor binding

From: Pharmacodynamics and pharmacokinetics of a new type of recombinant insulin Lisargine injection

Samples N = 1 N = 2 N = 3 Mean ± SEM P value
IC50 (nM) IC50 (nM) IC50 (nM) Vs. S-Insulin Lantus vs. Lisargine
S-Insulin 132.6 70.5 66.0 78.6 ± 10.8 / /
Lantus 12.6 12.3 13.4 12.9 ± 0.2 0.023 /
H-Insulin 49.2 52.8 39.2 45.4 ± 2.8 0.123 /
Lisargine 12.5 16.6 10.0 12.6 ± 1.3 0.024 0.897
  1. IC50 half maximal inhibitory concentration, SEM standard error of mean. S-Insulin Sigma Insulin, H-Insulin Human Insulin injection